Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Browsing: Pharma
Roche’s ctDNA-based approach to postoperative bladder cancer delivers results with Tecentriq agreement
By healthadmin
With help from DNA testing company Natera and its personalized molecular residual disease (MRD) blood…
While outgoing Commissioner Marty McCulley’s resignation is still pending, another top regulator may be on…
Biologics are increasingly replacing small molecules in the biopharmaceutical industry pipeline, and the increasing complexity…
Eisai slowly pushes Requembi toward blockbuster hit, gaining momentum with expected $900 million
By healthadmin
After doubling sales of Requenby, its Alzheimer’s disease drug partnered with Biogen, in fiscal 2025,…
The U.S. Supreme Court has issued an emergency order temporarily blocking a Louisiana federal appeals…
Bristol-Myers Squibb and Henry Pharma have signed a major contract worth up to $15.2 billion.…
When President Donald Trump announced his plan to impose 100% tariffs on patented medicines and…
Eli Lilly has made a six-year, $50 million commitment to UNICEF USA to support efforts…
AstraZeneca’s first foray into the PD-L1 inhibitor Imfinzi to treat bladder cancer was a huge…
Biopharmaceutical leaders are rallying behind Pazdur in his bid to become FDA commissioner. But does he want the role?
By healthadmin
With the FDA now rudderless with the announcement that Commissioner Marty McCully, M.D., is resigning,…